3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6096 |
Pretomanid
(S)-PA 824,PA-824 |
Antibacterial; Antibiotic | Microbiology/Virology |
Pretomanid ((S)-PA 824) 是一种抗生素,可研究肺部多重耐药性结核病。它对结核病(MTB) 具有亚微摩尔作用活性。它对 MTB 泛敏感和抗 Rifampin 的临床分离株的 MIC 值为 0.015 至 0.25 μg/mL。 | |||
T26963 |
CBR-2092
TNP2092,CBR2092,TNP-2092,TNP 2092 |
||
CBR-2092 is a DNA-directed RNA polymerase and DNA topoisomerase inhibitor. CBR-2092 exhibited rifampin-like potency as an inhibitor of RNA polymerase, was an equipotent (balanced) inhibitor of DNA gyrase and DNA topoisomerase IV, and retained activity against a prevalent quinolone-resistant variant. Studies of mutant strains that exhibited reduced susceptibility to CBR-2092 further substantiated RNA polymerase as the primary cellular target of CBR-2092, with DNA gyrase and DNA topoisomerase IV b... | |||
T37880 |
OPC-167832
|
||
OPC-167832 is a potent and orally active dprE1 Inhibitor with an IC50 of 0.258 μM. OPC-167832 has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis[1]. OPC-167832 exhibits very low MICs against laboratory strains of M. tuberculosis H37Rv (MIC: 0.0005 μg/ml) and Kurono (MIC: 0.0005 μg/ml) and strains with monoresistance to rifampin (RIF), isoniazid (INH), ethambutol (EMB), streptomycin (STR), and pyrazinamide (PZA) (MIC: 0.00024-0.001 ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T0681 |
Rifampicin
Rifamycin AMP,利福平,Rimactane,Rifampin |
Influenza Virus; DNA/RNA Synthesis; Antibacterial; Antibiotic; Antifection | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Rifampicin (Rifamycin AMP) 是广谱抗生素,可抵抗细菌病原体以及具有抗流感病毒活性。 |